Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new RA drug to see if it is safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 3 trial • 139 Patients • NCT02001987Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I am pregnant, breastfeeding, or planning to become pregnant.My veins are difficult to use for drawing blood.My partner is pregnant or we are planning to get pregnant.I am a male or female, regardless of my ability to have children.I weigh at least 50 kg.I agree to use contraception and not donate sperm.I do not have any diseases that pose a high risk.I have significant kidney problems.My liver tests or kidney function (eGFR) are abnormal due to my rheumatoid arthritis.I have been using certain drugs for a long time for my condition.I haven't taken any over-the-counter meds, vitamins, supplements, or herbal meds recently.I have not donated blood, plasma, or platelets recently.I haven't had a serious or sudden illness recently.I have significant liver problems.I am in good physical and mental health overall.I am between 18-55 years old as a healthy participant or 18-70 as someone with RA.I will avoid alcohol, caffeine, and certain foods before each clinic visit.I have active rheumatoid arthritis and have been treated with methotrexate.I agree to use birth control if I can have children and my partner is fertile.I am not pregnant or breastfeeding.You are in good overall health based on your medical history, physical exam, lab tests, ECG and vital signs, as determined by the doctor in charge of the study.
- Group 1: IA-14069 MAD
- Group 2: IA-14069 MAD RA patients
- Group 3: IA-14069 DDI
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it possible for me to join this medical experiment?
"This medical experiment is looking for 75 individuals with rheumatoid arthritis aged 18 to 70. The prerequisites are as follows: Gender (male or female, including non-childbearing and postmenopausal); Age Range (18 - 55 years old for healthy contributors in Part 1 and 18 - 70 years old for RA patients in Part 2 at screening); BMI (18 - 32 kg/m2 inclusive for healthy participants in part one and 18 – 40 kg/m2 inclusive for RA patients in part two at screening); Weight (>= 50kg inclusive at screening); Status (healthy subjects desired for part one, Rheumatoid Ar"
Are elderly participants being admitted for this research project?
"This clinical trial is only open to participants between the ages of 18 and 70. However, there are 101 studies available for people under age 18 and 699 trials suitable for individuals aged 65 or above."
Are any additional participants in the clinical trial being recruited currently?
"According to the clinicaltrials.gov listing, this healthcare trial is actively recruiting eligible candidates. The initial post was made on October 10th 2022 and it was last revised November 4th 2022."
What is the aggregate sum of participants joining this experiment?
"Confirmed. Per the information accessed via clinicaltrials.gov, this medical trial is still seeking participants to join in on their experiment. It was initially posted 10/10/2022 and subsequently updated 11/4/2022, with a goal of enrolling 75 individuals from one site."
Can IA-14069 be consumed with a minimal risk of adverse effects?
"Limited data exists to support safety and efficacy of IA-14069, so it receives a score 1 on our team's evaluation scale."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger